Osmotica Pharmaceutical Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Osmotica Pharmaceutical Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7542
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such as formulation research and development, analytical development, bioanalytical development, clinical development and laser drilling technologies, among others. Osmotica primarily provides development of therapies for the treatment of central nervous system (CNS) disorders. The company provides portfolio of products which are in various stages of development focused on the treatment of movement disorders. It also has operational presence in Argentina and Hungary. Osmotica is headquartered in Marietta, Georgia, the US.

Osmotica Pharmaceutical Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11
Partnerships 13
Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13
Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14
Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16
Licensing Agreements 17
Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17
Equity Offering 18
Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18
Acquisition 19
Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19
Osmotica Pharmaceutical Corp – Key Competitors 20
Osmotica Pharmaceutical Corp – Key Employees 21
Osmotica Pharmaceutical Corp – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Key Facts 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osmotica Pharmaceutical Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11
Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13
Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14
Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16
Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17
Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18
Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19
Osmotica Pharmaceutical Corp, Key Competitors 20
Osmotica Pharmaceutical Corp, Key Employees 21
Osmotica Pharmaceutical Corp, Other Locations 22
Osmotica Pharmaceutical Corp, Subsidiaries 22
Osmotica Pharmaceutical Corp, Joint Venture 23

List of Figures
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Osmotica Pharmaceutical Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Arc Logistics Partners LP (ARCX):石油・ガス:M&Aディール及び事業提携情報
    Summary Arc Logistics Partners LP (Arc Logistics Partners) is an oil and gas company that provides energy logistics services. The company owns and operates terminaling, storage, rail, transloading, and pipeline assets. It transports various products including gasoline, distillates, fuels, aviation g …
  • 3i Group Plc:企業の戦略・SWOT・財務情報
    3i Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3i Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • Huaneng Power International Inc:発電所・企業SWOT分析
    Huaneng Power International Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • European Medical Contract Manufacturing BV-医療機器分野:企業M&A・提携分析
    Summary European Medical Contract Manufacturing BV (EMCM BV), a subsidiary of Leader Biomedical Group, is a drug company that develops and manufactures sterile medicinal products. The company also manufactures liquids, powders, suspensions and gels. Its products include bone cements for hip and knee …
  • Qualicaps Inc:企業の戦略的SWOT分析
    Qualicaps Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Nestle Health Science SA:企業のM&A・事業提携・投資動向
    Nestle Health Science SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nestle Health Science SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Dermira Inc (DERM):企業の財務・戦略的SWOT分析
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Apache Corporation:企業の戦略・SWOT・財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • DCP Midstream LP (DCP):企業の財務・戦略的SWOT分析
    DCP Midstream LP (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Wheelock and Company Limited :企業の戦略・SWOT・財務情報
    Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report Summary Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • EllisDon Corporation:企業の戦略・SWOT・財務情報
    EllisDon Corporation - Strategy, SWOT and Corporate Finance Report Summary EllisDon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Marshall of Cambridge (Holdings) Ltd:企業の戦略・SWOT・財務情報
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Cox & Kings Limited
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Orange SA:企業の戦略・SWOT・財務情報
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Semtech Corp (SMTC):企業の財務・戦略的SWOT分析
    Summary Semtech Corp (Semtech) is a supplier of analog and mixed-signal semiconductor products. The company provides products such as isolated power switches, UHD-SDI gearbox, wireless charging ICs, battery chargers, cable drivers, capacitive touch controllers, charge pump and current sink led drive …
  • Rio Grande Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Rio Grande Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • BioTime Inc (BTX):企業の製品パイプライン分析2018
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆